Health News
Risk of neural tube defects slightly higher for babies of women on HIV therapy containing dolutegravir
- Details
- Written by Robert Bock Robert Bock
- Published: 26 July 2019 26 July 2019
Washington, DC - Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs.
Protect your heart in the heat
- Details
- Written by Suzanne Grant Suzanne Grant
- Published: 22 July 2019 22 July 2019
Dallas, Texas - With much of the nation facing a heat advisory this weekend, the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, is urging people to take precautions to protect their hearts.
FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections
- Details
- Written by YNN YNN
- Published: 21 July 2019 21 July 2019
Washington, DC - The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
Microvascular disease anywhere in the body may be linked to higher risk of leg amputations
- Details
- Written by Darcy Spitz Darcy Spitz
- Published: 22 July 2019 22 July 2019
Dallas, Texas - Microvascular disease is independently associated with a higher risk of leg amputation compared to people without the disease, according to new research in the American Heart Association’s journal Circulation.
NIH publishes the largest genomic study on type 2 diabetes in sub-Saharan African populations
- Details
- Written by Prabarna Ganguly, Ph.D. Prabarna Ganguly, Ph.D.
- Published: 19 July 2019 19 July 2019
Washington, DC - National Institute of Health researchers have reported the largest genomic study of type 2 diabetes (T2D) in sub-Saharan Africans, with data from more than 5,000 individuals from Nigeria, Ghana and Kenya. Researchers confirmed known genomic variants and identified a novel gene ZRANB3, which may influence susceptibility to the disease in sub-Saharan African populations.